The company is maintaining a full-year Ebitda margin guidance of 18.5-20% with US sales at a run rate of $1 billion by the end of the fiscal, as it plans to launch key new products during the year.
The company is maintaining a full-year Ebitda margin guidance of 18.5-20% with US sales at a run rate of $1 billion by the end of the fiscal, as it plans to launch key new products during the year.